Literature DB >> 8664

[Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)].

H Grobecker, G Planz, G Wiethold, R Simrock, H J Becker, E Lutz, P Petersen.   

Abstract

The effect of tyramine infusion or exercise on catecholamine concentration and dopamine-beta-hydroxylase activity in plasma of normal volunteers has been studied. Whereas the increase in plasma catecholamine concentrations by tyramine infusion was not changed 90 min after oral application of a single dose of beta-adrenoceptor blocking drugs (penbutolol, practolol, I.C.I. 66082), the increase in blood pressure was diminished. However, the increase in plasma catecholamine, concentration, i.e. the adrenergic response to exercise was significantly enhanced during beta-adrenoceptor blockade. On the other hand, dopamine-beta-hydroxylase activity was not further increased during beta-adrenoceptor blockade. - The non-specific membrane activity of the beta-adrenoceptor blocking drugs wass assessed by the degree of inhibition of serotonin uptake by human platelets in vitro. Their order of potency, according to IC 50 values estimated from the dose response curves was: propranolol less than penbutolol less than practolol less than I.C.I. 66082. The inhibitory activity of these drugs in vivo was also studied by measuring serotonin uptake by platelets isolated 90 min after oral administration. Due to the high dose only propranolol showed a marked membrane activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 8664     DOI: 10.1007/BF01614295

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Letter: Sympathoadrenal medullary activity in young, spontaneously hypertensive rats.

Authors:  G Grobecker; M F Roizen; V Weise; J M Saavedra; I J Kopin
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  Excretion of noradrenaline and adrenaline in muscular work.

Authors:  U S VON EULER; S HELLNER
Journal:  Acta Physiol Scand       Date:  1952-09-10

4.  On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs.

Authors:  N B Thoa; G F Wooten; J Axelrod; I J Kopin
Journal:  Mol Pharmacol       Date:  1975-01       Impact factor: 4.436

Review 5.  Dopamine- -hydroxylase: regulation of its synthesis and release from nerve terminals.

Authors:  J Axelrod
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

Review 6.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

7.  Serum dopamine-beta-hydroxylase activity.

Authors:  R Weinshilboum; J Axelrod
Journal:  Circ Res       Date:  1971-03       Impact factor: 17.367

Review 8.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

9.  A sensitive and specific fluorimetric method for the determination of noradrenalin and adrenalin in human plasma.

Authors:  V Renzini; C A Brunori; C Valori
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

10.  Effects of beta adrenergic blockade on plasma catecholamines in exercise.

Authors:  M H Irving; B J Britton; W G Wood; C Padgham; M Carruthers
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

View more
  7 in total

1.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

2.  [Plasma adrenaline and noradrenaline levels, age and exercise].

Authors:  M Lehmann; J Keul; G Huber; N Bachl; G Simon
Journal:  Klin Wochenschr       Date:  1981-01-02

3.  Elevated plasma catecholamines in young hypertensive and hyperkinetic patients: effect of pindolol.

Authors:  P Dominiak; H Grobecker
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Combined use of beta-sympathomimetic drugs and beta-blockers during labour.

Authors:  M Steyer; W Poleska; H P Diemer; H Schmidt; J Heidenreich
Journal:  Arch Gynecol       Date:  1981

5.  Excessive plasma dopamine increase at rest and during exercise after long-term beta-adrenoreceptor blockade in hypertensive patients.

Authors:  I W Franz; F W Lohmann; G Koch
Journal:  Br Heart J       Date:  1980-07

6.  Sympathomimetic effects of amezinium on the cardiovascular system and plasma catecholamines in man.

Authors:  G G Belz; P E Aust; G Belz; E Appel; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  [The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)].

Authors:  R Lang; A Maxrath; U Laaser; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1978-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.